logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Paula Cramer

University of Cologne
H指数:31
被引数:6,844

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transition Into Clinical Routine and Survival Outcomes of BCL2-and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry

BCL2和BTK抑制剂的临床常规应用及生存结局：一项基于GCLLSG登记数据的患者数据分析

EUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
2026-08-010
OAAI
Kutsch, Nadine; Ligtvoet, Rudy; Robrecht, Sandra; Linde, Hartmut; Illmer, Thomas; Dorfel, Steffen; Lipke, Jorg; Aldaoud, Ali; Schlag, Rudolf; Dengler, Jolanta; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Hallek, Michael; Eichhorst, Barbara; Fischer, Kirsten; Fink, Anna
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

MRD指导下的zanubrutinib、venetoclax和obinutuzumab在复发性CLL中的应用：CLL2-BZAG试验的主要终点分析

BLOOD
IF23.1
2025-01-301
PRE
Fuerstenau, Moritz; Robrecht, Sandra; Schneider, Christof; Tausch, Eugen; Giza, Adam; Ritgen, Matthias; Bittenbring, Joerg; Hebart, Holger; Schoettker, Bjoern; Illert, Anna Lena; Graeven, Ullrich; Stoltefuss, Andrea; Heinrich, Bernhard; Eckert, Robert; Fink, Anna; Stumpf, Janina; Fischer, Kirsten; Al-Sawaf, Othman; Simon, Florian; Kleinert, Fanni; Weiss, Jonathan; Kreuzer, Karl-Anton; Schilhabel, Anke; Brueggemann, Monika; Langerbeins, Petra; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Cramer, Paula
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-05-170
OAAI
Langerbeins, Petra; Giza, Adam; Robrecht, Sandra; Cramer, Paula; von Tresckow, Julia; Al-Sawaf, Othman; Fink, Anna Maria; Fuerstenau, Moritz; Kater, Arnon; van der Spek, Ellen; Niemann, Carsten Utoft; da Cunha-Bang, Caspar; Tausch, Eugen; Schneider, Christof; Stilgenbauer, Stephan; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-04-050
OAAI
Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Mueller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group

慢性淋巴细胞白血病患者的idelalisib治疗-来自德国CLL研究组注册表的真实数据

ANNALS OF HEMATOLOGY
IF2.4
2023-06-265
OAAI
von Tresckow, Julia; Heyl, Nikola; Robrecht, Sandra; Giza, Adam; Aldaoud, Ali; Schlag, Rudolf; Klausmann, Martine; Linde, Hartmut; Stein, Wolfgang; Schwarzer, Andreas; Fischer, Kirsten; Cramer, Paula; Eichhorst, Barbara; Hallek, Michael; Fink, Anna Maria
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial
LANCET HAEMATOLOGY
IF17.7
2022-10-019
PRE
Cramer, Paula; Furstenau, Moritz; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fink, Anna-Maria; Fischer, Kirsten; Langerbeins, Petra; Al-Sawaf, Othman; Tausch, Eugen; Schneider, Christof; Schetelig, Johannes; Dreger, Peter; Bottcher, Sebastian; Kreuzer, Karl-Anton; Schilhabel, Anke; Ritgen, Matthias; Bruggemann, Monika; Kneba, Michael; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
LEUKEMIA
IF13.4
2022-06-254
OAAI
von Tresckow, Julia; Cramer, Paula; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Fuerstenau, Moritz; Illmer, Thomas; Klaproth, Holger; Tausch, Eugen; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
HAEMATOLOGICA
IF7.9
2020-02-2715
OAAI
Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
LEUKEMIA
IF13.4
2019-11-147
PREAI
Fuerstenau, Moritz; Hopfinger, Georg; Robrecht, Sandra; Fink, Anna-Maria; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Von Tresckow, Julia; Maurer, Christian; Kutsch, Nadine; Hoechstetter, Manuela; Dreyling, Martin; Lange, Elisabeth; Kneba, Michael; Stilgenbauer, Stephan; Doehner, Hartmut; Hensel, Manfred; Kiehl, Michael G.; Jaeger, Ulrich; Wendtner, Clemens-Martin; Goede, Valentin; Fischer, Kirsten; von Bergwelt-Baildon, Michael; Eichhorst, Barbara; Hallek, Michael; Theurich, Sebastian
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2019-07-084
OAAI
Al-Sawaf, Othman; Bazeos, Alexandra; Robrecht, Sandra; Bahlo, Jasmin; Gower, Craig; Fink, Anna-Maria; Tresckow, Julia; Cramer, Paula; Langerbeins, Petra; Kutsch, Nadine; Humphrey, Kathryn; Fingerle-Rowson, Guenter; Stilgenbauer, Stephan; Wendtner, Clemens-Martin; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael; Goede, Valentin
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial
PHARMACEUTICAL RESEARCH
IF4.3
2019-05-014
PREAI
Lavezzi, Silvia Maria; de Jong, Jan; Neyens, Martine; Cramer, Paula; Demirkan, Fatih; Fraser, Graeme; Bartlett, Nancy; Dilhuydy, Marie-Sarah; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Samoilova, Olga; Goy, Andre; Ganguly, Siddhartha; Salman, Mariya; Howes, Angela; Mahler, Michelle; De Nicolao, Giuseppe; Poggesi, Italo
CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia
LEUKEMIA
IF13.4
2018-12-1940
PREAI
von Tresckow, Julia; Cramer, Paula; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Illmer, Thomas; Klaproth, Holger; Estenfelder, Sven; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
LEUKEMIA
IF13.4
2018-10-12101
OAAI
Fraser, G.; Cramer, P.; Demirkan, F.; Silva, R. Santucci; Grosicki, S.; Pristupa, A.; Janssens, A.; Mayer, J.; Bartlett, N. L.; Dilhuydy, M-S; Pylypenko, H.; Loscertales, J.; Avigdor, A.; Rule, S.; Villa, D.; Samoilova, O.; Panagiotidis, P.; Goy, A.; Pavlovsky, M. A.; Karlsson, C.; Hallek, M.; Mahler, M.; Salman, M.; Sun, S.; Phelps, C.; Balasubramanian, S.; Howes, A.; Chanan-Khan, A.

研究方向

暂未获取到该数据
M
Michael Hallek
H 指数:124论文数:1,647被引数:7.1万
S
Stephan Stilgenbauer
H 指数:126论文数:1,220被引数:7.3万
B
Barbara Eichhorst
H 指数:62论文数:439被引数:2.1万
K
Kirsten Fischer
H 指数:48论文数:389被引数:1.5万
A
Anna‐Maria Fink
H 指数:28论文数:134被引数:3,929
P
Petra Langerbeins
H 指数:23论文数:111被引数:2,418
O
Othman Al‐Sawaf
H 指数:34论文数:184被引数:6,459
J
Julia von Tresckow
H 指数:20论文数:104被引数:2,792
C
Clemens‐Martin Wendtner
H 指数:65论文数:436被引数:2.6万
S
Sandra Robrecht
H 指数:30论文数:152被引数:3,827